Biopharmaceutical Third Party Logistics Market Size Is Expected To Reach $145.2 Billion By 2028

 

Biopharmaceutical 3PL Market Growth & Trends

The global biopharmaceutical third party logistics market size is expected to reach USD 145.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.6% from 2021 to 2028. Rising demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the market growth. The rising adoption of automated storage and retrieval systems in emerging countries is an ongoing trend in pharmaceutical logistics companies that has gained significant traction.

The biopharmaceutical third party logistic players played a vital role in the fight against COVID-19 by minimizing supply disruptions and prioritizing critical care drugs. The future also seems good for the biopharmaceutical 3PL market with rising demand for domestic logistics coupled with favorable government initiatives and policies.

Furthermore, the trend of shifting from small molecule drugs to biopharmaceuticals, mainly vaccines & biologics, is projected to drive the market. Since these small molecule drugs are temperature-sensitive products, demand for temperature-controlled transportation and storage increases and thus is responsible for market growth.

Additionally, environmental concerns and cost have caused a slight shift in the means of transport used for commercial products, moving from airway to seaway shipping, and in roadways from trucks to intermodal (both rail and truck). Intermodal transport is majorly used by these pharmaceutical companies to reduce the carbon footprint. The ongoing trend shows that pharmaceutical manufacturers have shifted towards sea freight to reduce the cost and risk factors. Although for cold chain products, the companies still prefer air freight. However, some of the large pharmaceutical companies are planning to transport 70% of their products via ocean freight including cold chain products.

Request a free sample copy or view report summary: Biopharmaceutical Third Party Logistics Market Report

Biopharmaceutical 3PL Market Report Highlights

• In 2020, non-cold chain logistics held the largest market share of 80.8% in terms of revenue owing to the sales of a large number of drugs that do not require any temperature control
• The cold chain logistics segment is expected to register the faster CAGR of 8.6% over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
• Warehousing and storage held the largest market of 43.6% share among the types of services in 2020
• Asia Pacific is expected to emerge with the fastest CAGR of 7.2% over the forecast period owing to the adoption of medicines from the aging population and a shift of drug sales from brand manufacturers to generic

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biopharmaceutical-third-party-logistics-3pl-market

Biopharmaceutical 3PL Market Segmentation

Grand View Research has segmented the global biopharmaceutical 3PL market on the basis of the supply chain, service type, and region:

Biopharmaceutical Third Party Logistics Supply Chain Outlook (Revenue, USD Billion, 2016 - 2028)

• Cold Chain
• Non-cold Chain

Biopharmaceutical Third Party Logistics Service Type Outlook (Revenue, USD Billion, 2016 - 2028)

• Transportation
  • Air Freight
  • Sea Freight
  • Overland
• Warehousing and Storage
• Others

Biopharmaceutical Third Party Logistics Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK.
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • New Zealand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of key players in the Biopharmaceutical 3PL Market

• DHL International GmbH
• SF Express
• United Parcel Service of America, Inc.
• AmerisourceBergen Corporation
• DB Schenker
• KUEHNE + NAGEL
• Kerry Logistics Network Limited
• Agility

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Next-Generation Sequencing Data Analysis Market to Witness Tremendous Growth and Expansion by 2028

 Next-Generation Sequencing Data Analysis Market Growth & Trends

The global next-generation sequencing data analysis market size is expected to reach USD 1.72 billion by 2028 registering a CAGR of 15.02%, according to a new report by Grand View Research, Inc. Key drivers contributing to market expansion include the growing adoption of sequencing platforms for clinical diagnosis because of a significant reduction in the cost of installation. The easy availability of genomic and proteomic data is also expected to create lucrative growth opportunities in this market during the forecast period.

In addition, a decrease in the cost of sequencing is expected to increase the adoption of next-generation sequencing (NGS), which, in turn, is likely to boost the market growth. Availability of tools, such as Agilent’s HaloPlex capture system and Targeted Methyl-Seq platform from EpiGentek Group Inc., has helped in the determination of DNA methylation profiles in individual genomes. An increase in the adoption of bisulfite-methylation for targeted sequencing and targeted methylation NGS data analysis methods is anticipated to propel market growth.

EpigenDx, CD Genomics, Novogene Co., Ltd., and Epigentek Group, Inc. are the key players that offer methylation sequencing and targeted bisulfite sequencing data analysis services. The launch of new products will further boost revenue generation in the market. Major market participants have undertaken various strategic initiatives to strengthen their position in the market. For instance, in January 2021, Transnetyx, Inc. collaborated with One Codex to provide end-to-end analysis and microbiome sequencing services. This is expected to offer affordable sequencing analysis services to researchers.

Request a free sample copy or view report summary: Next-Generation Sequencing Data Analysis Market Report

Next-Generation Sequencing Data Analysis Market Report Highlights

• Services dominated the products segment in 2020 and will retain the leading position growing at the fastest CAGR during the forecast period
• Although NGS is advantageous in terms of affordability and speed, many research entities are unable to adopt it owing to a lack of sufficient computational infrastructure and skilled professionals to analyze the generated information
• Therefore, institutions that lack provision for data interpretation, analysis, and management adopt platforms & services offered by other companies in the market
• Tertiary analysis occupied a major portion of the revenue generated by the workflow segment as it accounts for the most complex and important step of Next-Generation Sequencing, which is directly linked with the interpretation of results
• In-house mode dominated the market in 2020 and is expected to maintain its dominance during the forecast period
• However, the outsourced mode is expected to register the fastest CAGR from 2021 to 2028 owing to the time and cost benefits associated with this mode and the presence of key players offering data analysis services
• The short-read sequencing segment led the global market in 2020 due to the wide adoption of these techniques as they are inexpensive and can work with fragment DNA along with the availability of several tools and algorithms
• The academic research end-use segment generated the largest revenue in 2020; however, clinical research is estimated to be the fastest-growing segment from 2021 to 2028
• North America dominated the global market in 2020 owing to the launch of large-scale genome sequencing projects and the rise in demand for personalized medicine

Access Press Release@ https://www.grandviewresearch.com/press-release/global-next-generation-sequencing-ngs-data-analysis-market

Next-Generation Sequencing Data Analysis Market Segmentation

Grand View Research has segmented the global next-generation sequencing data analysis market on the basis of product, workflow, mode, read length, end-use, and region:

Next-Generation Sequencing Data Analysis Product Outlook (Revenue, USD Million, 2017 - 2028)

• Services
• NGS Commercial Software
  • Platform OS/UI
  • Analytical Software
    • Alignment Tools & Software
      • DNA Seq Alignment
      • RNA Seq Alignment
      • Protein Seq Alignment
    • QC/Pre-processing Tools
    • Others

Next-Generation Sequencing Data AnalysisWorkflow Outlook (Revenue, USD Million, 2017 - 2028)

• Primary
• Secondary
  • Read Mapping
  • Variant Alignment & Variant Calling
• Tertiary
  • Variant Annotation
  • Application-specific
    • Targeted Sequencing/Gene Panel
    • Exome Sequencing
    • RNA Sequencing
    • Whole Genome Sequencing
    • ChIP-sequencing
    • Others

Next-Generation Sequencing Data AnalysisMode Outlook (Revenue, USD Million, 2017 - 2028)

• In-house
• Outsourced

Next-Generation Sequencing Data AnalysisRead Length Outlook (Revenue, USD Million, 2017 - 2028)

• Short Read
• Long Read
• Very Long Read

Next-Generation Sequencing Data AnalysisEnd-use Outlook (Revenue, USD Million, 2017 - 2028)

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other Users

Next-Generation Sequencing Data Analysis Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Next-Generation Sequencing (NGS) Data Analysis Market

• Thermo Fisher Scientific, Inc.
• QIAGEN
• Illumina, Inc.
• Hoffmann-La Roche Ltd.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• PierianDx
• Intrexon Bioinformatics Germany GmbH
• Partek, Inc.
• Eurofins Scientific
• Pacific Biosciences of California, Inc.
• DNASTAR, Inc.
• Congenica Ltd.
• Fabric Genomics, Inc.
• Genuity Science
• DNAnexus Inc.
• SciGenom Labs Pvt. Ltd.
• Golden Helix, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nephrology & Urology Devices Market is Predicted to Hit a Steady 6.6% CAGR through 2028

 

Nephrology And Urology Devices Market Growth & Trends

The global nephrology and urology devices market size is anticipated to reach USD 7.21 billion by 2028 registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. Unhealthy lifestyle and rise in smoking & alcohol consumption along with dietary irregularities are some of the factors resulting in urological and nephrological disorders. This is anticipated to increase the demand for devices to treat these disorders.

Increasing cases of Chronic Kidney Disease (CKD) are expected to boost the market growth. According to the National Kidney Foundation 2019, it is estimated that there are more than 2 million cases of CKD across the globe and this number continues to grow at a rate of 5-7% per year. Moreover, the growing adoption of minimally invasive procedures is expected to drive market growth.

Numerous non-invasive techniques have been introduced in the market, such as condom catheter, Doppler ultrasound video urodynamic, Intravesical Prostatic Protrusion (IPP), and penile cuff, which helps avoid painful catheterization. Technological advancements play a crucial role in driving market growth. For instance, certain companies introduced antimicrobial catheters to reduce catheter-associated infections and cases of thrombosis. Palindrome HSI heparin-coated & silver ion antimicrobial catheter by Medtronic PLC helps reduce clot formation and microbial colonization on the catheter surface.

Request a free sample copy or view report summary: Nephrology And Urology Devices Market Report

Nephrology And Urology Devices Market Report Highlights

• On the basis of product, the others segment dominated the market in 2020 with the share of 28.49%
• This growth can be attributed to the high prevalence of urological & nephrological disorders globally and the launch of technologically advanced products by the key players in this segment
• However, the Percutaneous Nephrostomy (PCN) catheters segment is expected to register the fastest CAGR of 7.6% from 2021 to 2028 due to the increasing application scope of PCN in various kidney-related medical conditions
• North America dominated the market with the highest revenue share of 33.20% in 2020 and will retain the leading position throughout the forecast period
• The presence of prominent players, advanced healthcare infrastructure, and high public funding in the healthcare system are some of the factors responsible for the region’s growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-nephrology-urology-devices-market

Nephrology And Urology Devices Market Segmentation

Grand View Research has segmented the global nephrology and urology devices market on the basis of product and region:

Nephrology & Urology Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Ureteral Catheters
• PCN Catheters
• Urinary Stents
• Stone Basket
• Urology Guidewires
• Renal Dilators
• Others

Nephrology & Urology Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Nephrology And Urology Devices Market

• Medtronic plc
• Fresenius Medical Care AG & Co. KGaA
• Baxter International, Inc.
• Boston Scientific Corp.
• R. Bard, Inc.
• Cook Group, Inc.
• Hollister, Inc.
• Nipro Corp.
• Terumo Corp.
• Coloplast A/S
• ConvaTec Group plc
• Braun AG
• Teleflex, Inc.
• Asahi Kasei Corp.
• Nxstage Medical, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Intravenous Solutions Market is Expected to Reach a Value of $18.9 Billion by 2028

 

IV Solutions Market Growth & Trends

The global intravenous solutions market size is expected to reach USD 18.9 billion by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.9% from 2021 to 2028. The growing incidence rate of chronic diseases such as cancer, increase in the number of premature births, and shortage of I.V. solutions in the U.S. are some of the key factors expected to drive the market.

One of the prime areas wherein intravenous (IV) fluids find usage is severe dehydration. Severe dehydration is seen in diseases such as diarrhea, resulting in the depletion of fluids from the body. According to the WHO, in 2017, diarrhea was the second leading cause of death in children under 5 years of age with around 5,25,000 lives lost each year. Intravenous (IV) fluids can play a key role in the treatment and prevention of deaths caused due to the dehydration/fluid loss associated with diarrhea. Other cases where intravenous fluids find application include surgeries and emergency situations.

The ongoing COVID-19 pandemic is expected to have a positive impact on the market. Intensive Care Units (ICU) worldwide are either operating at full capacity or are overcrowded due to the high influx of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As per an article published by BBC, in January 2021, critical care wards across England were running in full capacity. Nutritional care is one of the essential elements in managing these patients. This has increased the demand for intravenous (IV) fluids, as many of the patients, especially the elderly population are placed on ventilators and are unable to consume food orally.

Request a free sample copy or view report summary: IV Solutions Market Report

IV Solutions Market Report Highlights

• The Total Parenteral Nutrition (TPN) segment led the segment in terms of revenue share in 2020 owing to its growing applications in the management of chronic diseases
• The increasing number of surgeries and post-operative nutritional management is a prime factor driving the vitamins and minerals (salt and electrolyte) segment’s growth
• North America dominated the market with a revenue share of nearly 40.8% in 2020 due to the high usage of IV fluids in the U.S.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-intravenous-iv-solutions-market

IV Solutions Market Segmentation

Grand View Research has segmented the global IV solutions market based on type, nutrients, and region:

Intravenous Solutions Type Outlook (Revenue, USD Million, 2016 - 2028)

• Total Parenteral Nutrition (TPN)
• Peripheral Parenteral Nutrition (PPN)

Intravenous Solutions Nutrients Outlook (Revenue, USD Million, 2016 - 2028)

• Carbohydrates
• Single Dose Amino Acid Solution
• Vitamins & Minerals (Salt and electrolyte)
• Parenteral Lipid Emulsion
• Others

Intravenous Solutions Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Russia
  • Switzerland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of IV Solutions Market

• Hospira
• Terumo Corporation
• Braun Melsungen AG
• Fresenius Kabi
• Baxter

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Enteral Feeding Formulas Market to Incur Meteoric Growth During 2021 to 2028: Grand View Research Inc.

 Enteral Feeding Formulas Market Growth & Trends

The global enteral feeding formulas market size is expected to reach USD 9.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2021 to 2028. The growing prevalence of chronic diseases such as cancer, stroke, multiple sclerosis, dementia, chronic liver disease, Chronic Obstructive Pulmonary Disease (COPD), and diabetes is projected to drive the demand for products that support patients with oral intake issues. In addition, the rise in preterm births is one of the significant factors boosting the demand for enteral feeding formulas to meet the nutritional requirements of newborns.

Based on product, the standard formulas segment dominated the market and accounted for the largest revenue share of 54.0% in 2020. This high share is attributable to the availability of a vast variety of standard formulas coupled with increased demand for low-cost nutrient formulations. In addition, the demand with respect to standard tube feeds is significant among the volume-sensitive patients or the patients on fluid restrictions. Such conditions include renal failure, congestive heart failure, and Syndrome of Inappropriate Antidiuretic Hormone (SIADH).

In 2020, based on flow type, the intermittent feeding flow type segment accounted for the highest revenue share in the market because intermittent feeding has shown better tolerance in patients as compared to bolus feeding. Moreover, this type of feeding does not require feeding pumps, which is helpful in allowing greater mobility in between the feedings. This is expected to increase its adoption among the hospital as well as homecare settings, thereby affirmatively impacting the segment growth.

In 2020, based on stage, the adults' segment accounted for the highest revenue share of 88.4% in the market. The segment is projected to witness the fastest CAGR over the forecast period. The rising adoption of tube feeds in adults is one of the crucial factors driving the growth. In addition, the availability of large number of tube feeds or products for adults on a commercial level also contributes to the large share held by the segment. Glucerna, Osmolite, TwoCal, Vital, Promote, and Jevity are some of the popular brands by Abbott Nutrition for adults.

Based on indications, other indications, followed by cancer care accounted for the largest share in terms of revenue in 2020. The increasing prevalence of cancer and other health conditions associated with cancer is likely to promote market growth. For instance, according to GLOBOCON 2020, there were around 19.3 million new cases of cancer worldwide in 2020. Europe accounted for about 23.4% of total cancer cases and Asia had the highest population suffering from cancer, which was about 60%.

In 2020, based on end user, the homecare segment accounted for the highest revenue share in the market and this segment is projected to witness the fastest CAGR over the forecast period. The increasing number of patients that receive home enteral feeding due to growing awareness about complete and balanced nutrition is one of the key factors contributing to the growth of this segment. For instance, according to a recent survey conducted in the U.K., there were 187 patients on home enteral tube feeding out of the total 257 patients. This suggested that approximately 72% of patients were on home enteral tube feeding.

North America dominated the market with a revenue share of 29.7% in 2020 owing to the growing burden of chronic diseases such as diabetes, cancer, and other neurological conditions. Furthermore, increasing preference for home-based enteral therapy has decreased the number of patient visits to hospitals and clinics. In addition, increasing malnutrition is expected to further boost the demand for enteral feeding formulas in this region.

In addition, the rising number of COVID-19 cases in various geographies coupled with the large geriatric population, susceptible to various health conditions, are among the factors contributing to the growth of the market. For instance, according to an article published in Europe PMC in 2020, enteral nutrition is generally preferred over parenteral nutrition for COVID-19 patients admitted to the ICUs. In addition, it should be provided within 48 hours of admission. Hence, such instances signify increasing adoption of enteral feeding formulas during the pandemic.

Request a free sample copy or view report summary: Enteral Feeding Formulas Market Report

Enteral Feeding Formulas Market Report Highlights

• The market is anticipated to grow over the forecast period owing to the growing prevalence of chronic diseases and the rise in preterm births
• The standard formulas segment dominated the market in 2020, owing to the availability of a wide variety of standard formulas coupled with increased demand for low-cost nutrient formulations
• The intermittent feeding flow segment dominated the market in 2020, owing to better tolerance in patients shown by intermittent flow as compared to bolus feeding
• Adults accounted for the largest revenue share in the market in 2020 owing to the rising adoption of tube feeds in the adults and the availability of a large number of tube feeds or products for adults on the commercial level
• Other indications followed by cancer care accounted for the largest share in terms of revenue in 2020. The increasing prevalence of cancer and other health conditions associated with cancer is likely to promote market growth
• The homecare segment accounted for the highest revenue share in the market owing to the rising number of patients that receive home enteral feeding due to growing awareness about complete and balanced nutrition
• North America dominated the market with a revenue share of 29.7% in 2020 owing to the growing burden of chronic diseases such as diabetes, cancer, and other neurological conditions

Access Press Release@ https://www.grandviewresearch.com/press-release/global-enteral-feeding-formulas-market

Enteral Feeding Formulas Market Segmentation

Grand View Research has segmented the global enteral feeding formulas market based on product, flow type, stage, indications, end-user, and region:

Enteral Feeding Formulas Product Outlook (Revenue, USD Million, 2014 - 2028)

• Standard formula
• Disease-specific formula

Enteral Feeding Formulas Flow Type Outlook (Revenue, USD Million, 2014 - 2028)

• Intermittent feeding flow
• Continuous feeding flow

Enteral Feeding Formulas Stage Outlook (Revenue, USD Million, 2014 - 2028)

• Adult
• Pediatric

Enteral Feeding Formulas Indication Outlook (Revenue, USD Million, 2014 - 2028)

• Alzheimer’s
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others

Enteral Feeding Formulas End-user Outlook (Revenue, USD Million, 2014 - 2028)

• Hospitals
  • Cardiology
  • Neurology
  • Critical Care (ICU)
  • Oncology
  • Others
• Home Care

Enteral Feeding Formulas Regional Outlook (Revenue, USD Million, 2014 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
• Asia Pacific
  • Australia
  • China
  • Japan
  • South Korea
  • India
  • Singapore
  • New Zealand
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Enteral Feeding Formulas Market

• Abbott
• Danone SA
• Fresenius Kabi
• Nestlé
• Victus, Inc.
• Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co., Ltd.
• Rickett Benckiser Group Plc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Patient Engagement Solutions Market Trends, Company Share, Industry Growth And Future Scope: Grand View Research Inc.

 Patient Engagement Solutions Market Growth & Trends

The global patient engagement solutions market size is expected to reach USD 70.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 21.4% from 2021 to 2028. The market is expected to register exponential growth due to the adoption of m-health; increasing prevalence of chronic conditions such as diabetes, asthma, and arthritis; improved healthcare services; enhanced patient education; patient data tracking; and diagnostic treatment.

In January 2021, the Biden-Harris administration opened a “Special Enrollment Period”. Under this action, Americans to sign up for health coverage and roll back attacks on the Medicaid, Affordable Care Act, and access to reproductive health care. Hence, such orders meet the healthcare requirements formed by the COVID-19 outbreak, it will protect access to reproductive health care, and make health care system easier and more unbiassed. Such initiatives are anticipated to drive the demand for these services over the forecast period.

As healthcare providers were battling with the constant upsurge in numerous cases, patients were looking to digital technologies for the support which promoted the adoption of a product. The outbreak has resulted in the introduction of multiple COVID-19- related features patient engagement solutions by various players. The growing number of smartphone users around the globe expedited the adoption of mHealth across the sector both from providers and consumers which in turn, has augmented the dependability of patients on mHealth apps.

Moreover, in March 2019, the American Medical Association entered a collaboration with Patient Point with the aim to access point of care to help prevent the occurrence of cardiovascular diseases and type 2 diabetes. Using Patient Point technology, approximately 6,500 practicing doctors across U.S. are expected to educate individuals regarding disease prevention. Programs such as these are expected to drive market growth over the forecast period.

The necessity of social distancing resulted in the demand for remote patient monitoring solutions along with the prerequisite for the precise and timely exchange of patient wellbeing records. The pandemic has also made healthcare professionals look for alternate methods to traditional processes and systems. As a result, market participants had come up with COVID-19- related features into their existing patient engagement solutions. For instance, in 2020, Orion Health has established the first complete pandemic outbreak monitoring platform to control the spread of the coronavirus. Hence, it led to the adoption of the solutions.

Request a free sample copy or view report summary: Patient Engagement Solutions Market Report

Patient Engagement Solutions Market Report Highlights

• The web-based/cloud-based emerged as the largest delivery type segment in 2020 and accounted for over 80.0% revenue share as it supports hassle-free information flow between patients and healthcare providers. Moreover, bulk data can be stored in these platforms and enable remote access
• The software segment dominated the market in 2020, owing to continuous development in patient engagement solutions along with its increasing applications in consulting, education, and implementation. Software solutions are easy to install and use, enable quick access to specific drug information, and enable healthcare providers to digitally upload prescriptions
• Rising prevalence of chronic diseases such as cardiovascular diseases, obesity, and diabetes, which require constant monitoring, is expected to drive the demand for these services in the coming years
• The chronic diseases segment dominated the market in 2020 owing to the associated benefits of these solutions in chronic disease management. These solutions help patients connect with their healthcare providers from remote locations, thereby enabling streamlined flow of information, patient feedback, and other health-related data
• North America dominated the market in 2020 owing to increased adoption of m-health and Electronic Health Record (EHR) and growing investments in patient engagement software by major companies
• Companies are adopting various strategies to sustain competition. New product/solution development, partnerships, mergers, acquisitions, strategic collaborations, and geographical penetration are some of the key strategies adopted by market players  

Access Press Release of Patient Engagement Solutions Market@ https://www.grandviewresearch.com/press-release/global-patient-engagement-solutions-market

Patient Engagement Solutions Market Segmentation

Grand View Research has segmented the global patient engagement solutions market based on delivery type, component, end-use, application, therapeutic area, and region:

Patient Engagement Solutions Delivery Type Outlook (Revenue, USD Million, 2016 - 2028)

• Web-based/Cloud-based
• On-premise

Patient Engagement Solutions Component Outlook (Revenue, USD Million, 2016 - 2028)

• Software
  • Standalone
  • Integrated
• Services
  • Consulting
  • Implementation
  • Education
  • Others
• Hardware

Patient Engagement Solutions End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Payers
• Providers
• Individual Users

Patient Engagement Solutions Application Outlook (Revenue, USD Million, 2016 - 2028)

• Social Management
• Health Management
• Home Healthcare Management
• Financial Health Management

Patient Engagement Solutions Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2028)

• Chronic diseases
  • Obesity
  • Diabetes
  • Cardiovascular
  • Others
• Fitness
• Women's Health
• Mental Health
• Others

Patient Engagement Solutions Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Patient Engagement Solutions Market

• Allscripts Healthcare Solutions
• McKesson Corporation
• Orion Health Ltd.
• Cerner Corporation
• Phytel Inc.
• Medecision Inc.
• GetWellNetwork Inc.
• YourCareUniverse Inc.
• Lincor Solutions Ltd.
• Athenahealth, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Extracorporeal Membrane Oxygenation Machine Market Plying for Significant Growth During 2021-2028

 Extracorporeal Membrane Oxygenation Machine Market Growth & Trends

The global extracorporeal membrane oxygenation machine market size is expected to reach USD 398.6 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.1% from 2021 to 2028. The market is primarily driven by the increasing incidence of cardiopulmonary and respiratory diseases and technological advancement in the field of ECMO procedures. Cardiovascular disease is one of the leading causes of death globally.

According to the WHO, 17.9 million people died from cardiovascular diseases in 2016. In addition, according to the Extracorporeal Life Support Organization, a total of 45,035 patients globally suffered from respiratory illnesses in 2016. Furthermore, increasing awareness about ECMO procedures, coupled with various government initiatives, is further propelling the growth.

The increasing survival rate of ECMO machine supported surgery for cardiac and respiratory patients is also augmenting the market growth. Applications of ECMO machine procedures have been increased over the years. ECMO machine was traditionally used in cases of circulatory or respiratory failure. Its applications have expanded to use as rescue therapy for post-organ transplantation and sepsis and in cases of heart failure.

The ECMO machine use has been rising gradually worldwide owing to its benefits such as artificial lung for the patients and growing awareness about its use. Moreover, increasing healthcare expenditure by government and private agencies in order to improve healthcare facilities is adding growth to the market. According to the American Heart Association, medical expenditure related to CVDs is expected to reach USD 960 billion by 2030 from USD 320 billion in 2011. Major players in the market are focusing on technological collaboration and product launches.

Request a free sample copy or view report summary: Extracorporeal Membrane Oxygenation Machine Market Report

Extracorporeal Membrane Oxygenation Machine Market Report Highlights

• North America accounted for the largest share in 2020 owing to favorable reimbursement policies, the presence of key players, and government initiatives
• By component, the oxygenator segment accounted for the largest share in 2020 owing to its high cost and usage
• In terms of modality, the veno-arterial segment accounted for the largest share in 2020 and is expected to grow at the fastest rate during the forecast period
• Based on patient type, the adult segment is expected to grow at a rapid pace during the forecast period owing to the rising incidence of cardiac and pulmonary diseases
• On the basis of application, the respiratory segment held the largest market share in 2020 and is expected to grow at the fastest rate over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-extracorporeal-membrane-oxygenation-ecmo-market

Extracorporeal Membrane Oxygenation Machine Market Segmentation

Grand View Research has segmented the global extracorporeal membrane oxygenation machine market on the basis of component, modality, patient type, application, and region:

ECMO Machine Component Outlook (Revenue, USD Million, 2016 - 2028)

• Pumps
• Oxygenator
• Controllers
• Cannula
• Accessories

ECMO Machine Modality Outlook (Revenue, USD Million, 2016 - 2028)

• Veno-Arterial
• Veno-Venous
• Arterio-Venous

ECMO Machine Patient Type Outlook (Revenue, USD Million, 2016 - 2028)

• Neonates
• Pediatric
• Adult

ECMO Machine Application Outlook (Revenue, USD Million, 2016 - 2028)

• Respiratory
  • Neonates
  • Pediatric
  • Adult
• Cardiac
  • Neonates
  • Pediatric
  • Adult
• ECPR
  • Neonates
  • Pediatric
  • Adult

ECMO Machine Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Czech Republic
  • Russia
  • Poland
  • Turkey
  • Switzerland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Vietnam
  • Philippines
  • Malaysia
  • Indonesia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Oman
  • Kuwait

List of Key Players of Extracorporeal Membrane Oxygenation Machine Market

• Medtronic plc
• Sorin Group
• Terumo Cardiovascular Systems Corporation
• MAQUET Holding B.V. & Co. KG
• Medos Medizintechnik AG
• Nipro Medical Corporation
• Microport Scientific Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Vital Signs Monitoring Devices Market Revenue Sales to Reach $15.6 Billion by 2028

 Vital Signs Monitoring Devices Market Growth & Trends

The global vital signs monitoring devices market size is expected to reach USD 15.6 billion by 2028, according to the new report of Grand View Research, Inc. It is expected to expand at a CAGR of 8.9% over the forecast period. The growing prevalence of lifestyle-associated chronic conditions and rising demand for advanced monitoring devices in developing countries, such as China, India, Thailand, and Brazil, are some of the major factors driving the market. The availability of monitoring systems at competitive prices and increasing disposable income are expected to fuel the market growth during the forecast period.

The introduction of advanced, integrated vital signs monitoring solutions and the growing trend of the usage of these devices in home healthcare settings as well as all-time wearable devices for chronic patients are some of the factors expected to drive the market during the forecast period.

Blood pressure monitors emerged as the largest product segment in the market in 2020 due to the increasing incidence of hypertension and rising demand for blood pressure monitors designed for personal use. The hospitals' end-use segment dominated the market in 2020 due to the factors such as a large patient pool, financing capability, and requirement of vital signs monitors in bulk.

The demand for vital signs monitoring devices escalated due to the outbreak of COVID as a daily measurement of the vital sign can serve as an early detection system for the infection. These devices can also provide facility-based surveillance for healthcare-associated infections, including infections in healthcare workers and patients, which is one of the vital components of COVID-19 infection prevention and control measures. The use of vital signs monitoring for in-home settings also saw a surge w.r.t maintaining patient and provider safety while also allowing real-time access to vital signs via Cloud Portals.

Request a free sample copy or view report summary: Vital Signs Monitoring Devices Market Report

Vital Signs Monitoring Devices Market Report Highlights

• By product, blood pressure monitors held the largest market share in 2020 and are expected to exhibit a lucrative CAGR from 2021 to 2028
• Based on end-use, the hospitals' segment dominated the market in 2020. The segment is expected to maintain its lead throughout the forecast period owing to the high preference for advanced devices
• North America dominated the market in 2020 owing to the availability of major market players and high adoption of advanced technology
• Various manufactures are focusing on new product launches, technological innovations, collaborations, and regional expansion as major strategic initiatives

Access Press Release@ https://www.grandviewresearch.com/press-release/global-vital-signs-monitoring-devices-market

Vital Signs Monitoring Devices Market Segmentation

Grand View Research has segmented the global vital signs monitoring devices market on the basis of product, end-use, and region:

Vital Signs Monitoring Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Blood Pressure Monitors
  • Mercury Blood Pressure Monitors
  • Aneroid Blood Pressure Monitors
  • Digital Blood Pressure Monitors
  • Ambulatory Blood Pressure Monitors
  • Blood Pressure Instrument Accessories
• Pulse Oximeters
  • Table-Top/Bedside Pulse Oximeters
  • Fingertip Pulse Oximeters
  • Hand-Held Pulse Oximeters
  • Wrist-Worn Pulse Oximeters
  • Pediatric Pulse Oximeters
  • Pulse Oximeter Accessories
• Temperature Monitoring Devices
  • Mercury Filled Thermometers
  • Digital Thermometers
  • Infrared Thermometers
  • Liquid Crystal Thermometer
  • Temperature Monitoring Device Accessories
• Other Vital Sign Monitors

Vital Signs Monitoring Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Physician’s Office
• Home Healthcare
• Ambulatory Centers
• Emergency Care Centers
• Other Healthcare Settings

Vital Signs Monitoring Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Vital Signs Monitoring Devices Market

• Koninklijke Philips N.V.
• Medtronic
• Nihon Kohden Corporation
• GE Healthcare
• Masimo
• Omron Healthcare
• Contec Medical Systems Co. Ltd.
• A&D Company Ltd.
• Nonin Medical Inc.
• SunTech Medical, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antibiotics Market Value Expected to Increase at a CAGR of 4.5% by 2028

 

Antibiotics Market Growth & Trends 

The global antibiotics market size is expected to reach USD 57.99 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.5% from 2021 to 2028. High usage of antibiotics and inappropriate prescription behavior of antibiotic drugs worldwide are the major factors anticipated to drive the market. Moreover, rising awareness among patients and healthcare professionals and increasing involvement of regulatory bodies in the R&D activities of new therapies to treat infectious diseases are expected to propel the market growth over the forecast period.

An increasing number of public-private collaborations, wherein funding and innovative R&D approaches are provided by public agencies to firms developing antibiotics, is expected to boost the product pipeline. For instance, in December 2018, Eisai Co., Ltd., and Takeda Pharmaceutical Company Limited announced an agreement with GARDP for the development of novel antibacterial compounds.

Betterment in the approval process of antibiotic drugs is expected to boost the market growth over the forecast period. In February 2020, Merck received acceptance for a review of supplemental New Drug Application (sNDA) from the U.S. FDA for RECARBRIO (imipenem, cilastatin, and relebactam) intended for HABP/VABP. This submission is anticipated to reinforce the continued dedication of the company to R&D pertaining to antibiotic therapies that address unmet medical needs.

Government reforms such as the Generating Antibiotics Incentives Now Act in the U.S. are projected to propel market growth in the coming years. This is further expected to facilitate the development process of advanced drugs. According to the Pew Charitable Trusts, about 30% of the outpatient oral antibiotic drug prescriptions are unnecessary and most of these prescriptions are for disease conditions against which antibiotics are not significantly effective, such as non-bacterial infections and acute respiratory conditions.

The market is highly competitive and major market players have almost similar market share. Pharmaceutical players are adopting strategies, including mergers & acquisitions, collaborations, and strategic alliances, to gain a competitive advantage. The major pharmaceutical companies are collaborating for developing novel therapies to reduce the cost burden of the drug development process. In December 2019, Appili Therapeutics signed an agreement with Saptalis Pharmaceuticals for the reformulation of antibiotic metronidazole. According to the agreement, Saptalis will be responsible for manufacturing, marketing of ATI-1501 in the United States. Moreover, in October 2018, Paratek Pharmaceuticals, Inc. entered into a license agreement for the development and commercialization of Seysara (sarecyline) with Allergan.

A group of key pharmaceutical players has launched AMR Action Fund worth USD 1 billion in July 2020. This fund is expected to support the research of innovative and novel antibiotics and is formed in collaboration with the European Investment Bank, the Wellcome Trust, and the World Health Organization.

Due to the lack of commercial success for newly developed antimicrobial drugs, government and non-government bodies have adopted strategies to incentivize antibiotic drug R&D activities. For instance, the government in alliance with BARDA is supporting several companies to boost the R&D activities in new therapies for infectious diseases. BARDA has also been associated with pharmaceutical companies, such as GSK, Tetraphase, and Basilea Astra Zeneca. CARB-X is investing around USD 109 million to support the early-stage development of potential therapeutic candidates.

Request a free sample copy or view report summary: Antibiotics Market Report

Antibiotics Market Report Highlights

• By action mechanism, the cell wall synthesis inhibitors segment accounted for the largest share of 52.1% in 2020 and is anticipated to maintain its lead over the forecast period
• Based on drug class, the cephalosporin segment held the second-largest share in 2020. Pipeline candidates in cephalosporin drug class such as Fetroja (cefiderocol), cefilavancin, and ceftobiprole are anticipated to drive the segment in the forecast period
• The others' drug class segment is expected to grow at the fastest rate during the forecast period. The segment consists of various existing classes of antibiotics as well as some newly developed drugs, such as tetracycline, carbapenem, imidazole, peptides, lincosamides, and monoclonal antibodies
• Asia Pacific was the largest regional market in 2020 and is expected to witness the fastest growth in the coming years owing to the rising consumption of antibiotics and high disease prevalence
• North America emerged as the second-largest regional market in 2020 owing to government initiatives for the development of new therapies and better reimbursement scenario

Access Press Release@ https://www.grandviewresearch.com/press-release/global-antibiotic-market

Antibiotics Market Segmentation

Grand View Research has segmented the global antibiotics market on the basis of action mechanism, drug class, and region:

Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2017 - 2028)

• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• DNA Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Others

Antibiotics Drug Class Outlook (Revenue, USD Million, 2017 - 2028)

• Cephalosporin
• Penicillin
• Fluoroquinolone
• Macrolide
• Carbapenem
• Aminoglycoside
• Sulfonamide
• 7-ACA
• Others

Antibiotics Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players of Antibiotics Market

• Merck & Co., Inc.
• Allergan plc (AbbVie)
• GlaxoSmithKline plc.
• Pfizer Inc.
• Melinta Therapeutics
• Basilea Pharmaceutica Ltd.
• Tetraphase Pharmaceuticals
• Paratek Pharmaceuticals, Inc.
• Nabriva Therapeutics plc
• Spero Therapeutics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.